Resolving E1 regulates inflammatory cellinfiltration and cytokine production in diabeticperiodontitis


Creative Commons License

Öner F., Yaghmoor W., Stephans D., Hastürk H., Fıratlı H. E., Vandyke T., ...Daha Fazla

EuroPerio 10, Kobenhavn, Danimarka, 15 - 18 Haziran 2022, cilt.49, sa.6, ss.6

  • Yayın Türü: Bildiri / Özet Bildiri
  • Cilt numarası: 49
  • Doi Numarası: 10.1111/jcpe.13634
  • Basıldığı Şehir: Kobenhavn
  • Basıldığı Ülke: Danimarka
  • Sayfa Sayıları: ss.6
  • İstanbul Üniversitesi Adresli: Evet

Özet

Background and Aim: Diabetic periodontitis involves a complexinflammatory process where periodontitis and diabetes aggravate theseverity of the other. We hypothesized that Resolvin E1 (RvE1), apro-resolution mediator of inflammation, decreases inflammatory cellinfiltrate and pro-inflammatory cytokine expression in diabeticperiodontitis through active ligand-receptor activation.Methods: The db/db mouse (leptin receptor mutation) was crossbredwith ERV1 transgenic mice (overexpresses receptor for RvE1) to gener-ate double-mutant mice (db/db-ERV1).Wild-type (WT) and transgenicmice overexpressing ERV1 only were used as controls. Experimentalperiodontitis was induced with 7-0 silk ligatures tied around the maxillarysecond molars. Half of the animals received 10 mM RvE1 daily for7 days. Gingival expression of IL-17+and IL-2+cells was evaluated byimmunohistochemistry. Peripheral blood serum samples were tested forIL-17A, IL-17F, CCL20, IL-6, and IL-10 by multiplex immunoassay.Results: Diabetic mice exhibited significantly more bone loss, withincreased levels of IL-6, IL-17, CCL20, and IL-10 at baseline comparedto the WT animals (p < 0.001). db/db-ERV1 mice were protected fromthe increased inflammatory phenotype and periodontal disease(p < 0.001 compared to db/db mice). Experimental periodontitis led toa significant increase in cytokine levels in all groups; however, it wassignificantly lower in the db/db-ERV1 mice compared to the diabeticand WT groups (p < 0.05). RvE1 treatment prevented experimentalperiodontitis-induced cytokine production in all groups; with a moresignificant impact on the db/db ERV1 group. Periodontitis increasedthe percentage of IL-17+cells in tissues in all groups; RvE1 treatmentprevented this increase in ERV1, db/db, and db/ERV1 mice anddecreased IL-2+cells in db/db and db/db ERV1 mice (p < 0.05).Conclusions: RvE1 resolves inflammation and restores periodontalhomeostasis through receptor-mediated activity and prevents excessinflammation induced by periodontitis in diabetic mice